Global Primary Hyperoxaluria Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Primary Hyperoxaluria Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Primary Hyperoxaluria Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Primary Hyperoxaluria Drug by Country/Region, 2017, 2022 & 2028

2.2 Primary Hyperoxaluria Drug Segment by Type

2.2.1 ALLN-230

2.2.2 DCR-PHXC

2.2.3 ALN-GO1

2.2.4 Others

2.3 Primary Hyperoxaluria Drug Sales by Type

2.3.1 Global Primary Hyperoxaluria Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Primary Hyperoxaluria Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Primary Hyperoxaluria Drug Sale Price by Type (2017-2022)

2.4 Primary Hyperoxaluria Drug Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Primary Hyperoxaluria Drug Sales by Application

2.5.1 Global Primary Hyperoxaluria Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Primary Hyperoxaluria Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Primary Hyperoxaluria Drug Sale Price by Application (2017-2022)

3 Global Primary Hyperoxaluria Drug by Company

3.1 Global Primary Hyperoxaluria Drug Breakdown Data by Company

3.1.1 Global Primary Hyperoxaluria Drug Annual Sales by Company (2020-2022)

3.1.2 Global Primary Hyperoxaluria Drug Sales Market Share by Company (2020-2022)

3.2 Global Primary Hyperoxaluria Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Primary Hyperoxaluria Drug Revenue by Company (2020-2022)

3.2.2 Global Primary Hyperoxaluria Drug Revenue Market Share by Company (2020-2022)

3.3 Global Primary Hyperoxaluria Drug Sale Price by Company

3.4 Key Manufacturers Primary Hyperoxaluria Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Primary Hyperoxaluria Drug Product Location Distribution

3.4.2 Players Primary Hyperoxaluria Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Primary Hyperoxaluria Drug by Geographic Region

4.1 World Historic Primary Hyperoxaluria Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Primary Hyperoxaluria Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Primary Hyperoxaluria Drug Annual Revenue by Geographic Region

4.2 World Historic Primary Hyperoxaluria Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Primary Hyperoxaluria Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Primary Hyperoxaluria Drug Annual Revenue by Country/Region

4.3 Americas Primary Hyperoxaluria Drug Sales Growth

4.4 APAC Primary Hyperoxaluria Drug Sales Growth

4.5 Europe Primary Hyperoxaluria Drug Sales Growth

4.6 Middle East & Africa Primary Hyperoxaluria Drug Sales Growth

5 Americas

5.1 Americas Primary Hyperoxaluria Drug Sales by Country

5.1.1 Americas Primary Hyperoxaluria Drug Sales by Country (2017-2022)

5.1.2 Americas Primary Hyperoxaluria Drug Revenue by Country (2017-2022)

5.2 Americas Primary Hyperoxaluria Drug Sales by Type

5.3 Americas Primary Hyperoxaluria Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Primary Hyperoxaluria Drug Sales by Region

6.1.1 APAC Primary Hyperoxaluria Drug Sales by Region (2017-2022)

6.1.2 APAC Primary Hyperoxaluria Drug Revenue by Region (2017-2022)

6.2 APAC Primary Hyperoxaluria Drug Sales by Type

6.3 APAC Primary Hyperoxaluria Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Primary Hyperoxaluria Drug by Country

7.1.1 Europe Primary Hyperoxaluria Drug Sales by Country (2017-2022)

7.1.2 Europe Primary Hyperoxaluria Drug Revenue by Country (2017-2022)

7.2 Europe Primary Hyperoxaluria Drug Sales by Type

7.3 Europe Primary Hyperoxaluria Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Primary Hyperoxaluria Drug by Country

8.1.1 Middle East & Africa Primary Hyperoxaluria Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Primary Hyperoxaluria Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Primary Hyperoxaluria Drug Sales by Type

8.3 Middle East & Africa Primary Hyperoxaluria Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Primary Hyperoxaluria Drug

10.3 Manufacturing Process Analysis of Primary Hyperoxaluria Drug

10.4 Industry Chain Structure of Primary Hyperoxaluria Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Primary Hyperoxaluria Drug Distributors

11.3 Primary Hyperoxaluria Drug Customer

12 World Forecast Review for Primary Hyperoxaluria Drug by Geographic Region

12.1 Global Primary Hyperoxaluria Drug Market Size Forecast by Region

12.1.1 Global Primary Hyperoxaluria Drug Forecast by Region (2023-2028)

12.1.2 Global Primary Hyperoxaluria Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Primary Hyperoxaluria Drug Forecast by Type

12.7 Global Primary Hyperoxaluria Drug Forecast by Application

13 Key Players Analysis

13.1 Allena Pharmaceuticals Inc

13.1.1 Allena Pharmaceuticals Inc Company Information

13.1.2 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Offered

13.1.3 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Allena Pharmaceuticals Inc Main Business Overview

13.1.5 Allena Pharmaceuticals Inc Latest Developments

13.2 Alnylam Pharmaceuticals Inc

13.2.1 Alnylam Pharmaceuticals Inc Company Information

13.2.2 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Offered

13.2.3 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Alnylam Pharmaceuticals Inc Main Business Overview

13.2.5 Alnylam Pharmaceuticals Inc Latest Developments

13.3 Dicerna Pharmaceuticals Inc

13.3.1 Dicerna Pharmaceuticals Inc Company Information

13.3.2 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Offered

13.3.3 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Dicerna Pharmaceuticals Inc Main Business Overview

13.3.5 Dicerna Pharmaceuticals Inc Latest Developments

13.4 Intellia Therapeutics Inc

13.4.1 Intellia Therapeutics Inc Company Information

13.4.2 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product Offered

13.4.3 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Intellia Therapeutics Inc Main Business Overview

13.4.5 Intellia Therapeutics Inc Latest Developments

13.5 OxThera AB

13.5.1 OxThera AB Company Information

13.5.2 OxThera AB Primary Hyperoxaluria Drug Product Offered

13.5.3 OxThera AB Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 OxThera AB Main Business Overview

13.5.5 OxThera AB Latest Developments

14 Research Findings and Conclusion

Table 1. Primary Hyperoxaluria Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Primary Hyperoxaluria Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of ALLN-230

Table 4. Major Players of DCR-PHXC

Table 5. Major Players of ALN-GO1

Table 6. Major Players of Others

Table 7. Global Primary Hyperoxaluria Drug Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Primary Hyperoxaluria Drug Sales Market Share by Type (2017-2022)

Table 9. Global Primary Hyperoxaluria Drug Revenue by Type (2017-2022) & ($ million)

Table 10. Global Primary Hyperoxaluria Drug Revenue Market Share by Type (2017-2022)

Table 11. Global Primary Hyperoxaluria Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Primary Hyperoxaluria Drug Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Primary Hyperoxaluria Drug Sales Market Share by Application (2017-2022)

Table 14. Global Primary Hyperoxaluria Drug Revenue by Application (2017-2022)

Table 15. Global Primary Hyperoxaluria Drug Revenue Market Share by Application (2017-2022)

Table 16. Global Primary Hyperoxaluria Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Primary Hyperoxaluria Drug Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Primary Hyperoxaluria Drug Sales Market Share by Company (2020-2022)

Table 19. Global Primary Hyperoxaluria Drug Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Primary Hyperoxaluria Drug Revenue Market Share by Company (2020-2022)

Table 21. Global Primary Hyperoxaluria Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Primary Hyperoxaluria Drug Producing Area Distribution and Sales Area

Table 23. Players Primary Hyperoxaluria Drug Products Offered

Table 24. Primary Hyperoxaluria Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Primary Hyperoxaluria Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Primary Hyperoxaluria Drug Sales Market Share Geographic Region (2017-2022)

Table 29. Global Primary Hyperoxaluria Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Primary Hyperoxaluria Drug Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Primary Hyperoxaluria Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Primary Hyperoxaluria Drug Sales Market Share by Country/Region (2017-2022)

Table 33. Global Primary Hyperoxaluria Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Primary Hyperoxaluria Drug Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Primary Hyperoxaluria Drug Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Primary Hyperoxaluria Drug Sales Market Share by Country (2017-2022)

Table 37. Americas Primary Hyperoxaluria Drug Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Primary Hyperoxaluria Drug Revenue Market Share by Country (2017-2022)

Table 39. Americas Primary Hyperoxaluria Drug Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Primary Hyperoxaluria Drug Sales Market Share by Type (2017-2022)

Table 41. Americas Primary Hyperoxaluria Drug Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Primary Hyperoxaluria Drug Sales Market Share by Application (2017-2022)

Table 43. APAC Primary Hyperoxaluria Drug Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Primary Hyperoxaluria Drug Sales Market Share by Region (2017-2022)

Table 45. APAC Primary Hyperoxaluria Drug Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Primary Hyperoxaluria Drug Revenue Market Share by Region (2017-2022)

Table 47. APAC Primary Hyperoxaluria Drug Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Primary Hyperoxaluria Drug Sales Market Share by Type (2017-2022)

Table 49. APAC Primary Hyperoxaluria Drug Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Primary Hyperoxaluria Drug Sales Market Share by Application (2017-2022)

Table 51. Europe Primary Hyperoxaluria Drug Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Primary Hyperoxaluria Drug Sales Market Share by Country (2017-2022)

Table 53. Europe Primary Hyperoxaluria Drug Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Primary Hyperoxaluria Drug Revenue Market Share by Country (2017-2022)

Table 55. Europe Primary Hyperoxaluria Drug Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Primary Hyperoxaluria Drug Sales Market Share by Type (2017-2022)

Table 57. Europe Primary Hyperoxaluria Drug Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Primary Hyperoxaluria Drug Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Primary Hyperoxaluria Drug Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Primary Hyperoxaluria Drug Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Primary Hyperoxaluria Drug Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Primary Hyperoxaluria Drug Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Primary Hyperoxaluria Drug Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Primary Hyperoxaluria Drug Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Primary Hyperoxaluria Drug Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Primary Hyperoxaluria Drug Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Primary Hyperoxaluria Drug

Table 68. Key Market Challenges & Risks of Primary Hyperoxaluria Drug

Table 69. Key Industry Trends of Primary Hyperoxaluria Drug

Table 70. Primary Hyperoxaluria Drug Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Primary Hyperoxaluria Drug Distributors List

Table 73. Primary Hyperoxaluria Drug Customer List

Table 74. Global Primary Hyperoxaluria Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Primary Hyperoxaluria Drug Sales Market Forecast by Region

Table 76. Global Primary Hyperoxaluria Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Primary Hyperoxaluria Drug Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Primary Hyperoxaluria Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Primary Hyperoxaluria Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Primary Hyperoxaluria Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Primary Hyperoxaluria Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Primary Hyperoxaluria Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Primary Hyperoxaluria Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Primary Hyperoxaluria Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Primary Hyperoxaluria Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Primary Hyperoxaluria Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Primary Hyperoxaluria Drug Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Primary Hyperoxaluria Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Primary Hyperoxaluria Drug Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Primary Hyperoxaluria Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Primary Hyperoxaluria Drug Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Primary Hyperoxaluria Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Primary Hyperoxaluria Drug Revenue Market Share Forecast by Application (2023-2028)

Table 94. Allena Pharmaceuticals Inc Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Offered

Table 96. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. Allena Pharmaceuticals Inc Main Business

Table 98. Allena Pharmaceuticals Inc Latest Developments

Table 99. Alnylam Pharmaceuticals Inc Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Offered

Table 101. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. Alnylam Pharmaceuticals Inc Main Business

Table 103. Alnylam Pharmaceuticals Inc Latest Developments

Table 104. Dicerna Pharmaceuticals Inc Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Offered

Table 106. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. Dicerna Pharmaceuticals Inc Main Business

Table 108. Dicerna Pharmaceuticals Inc Latest Developments

Table 109. Intellia Therapeutics Inc Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product Offered

Table 111. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. Intellia Therapeutics Inc Main Business

Table 113. Intellia Therapeutics Inc Latest Developments

Table 114. OxThera AB Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. OxThera AB Primary Hyperoxaluria Drug Product Offered

Table 116. OxThera AB Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. OxThera AB Main Business

Table 118. OxThera AB Latest Developments

List of Figures

Figure 1. Picture of Primary Hyperoxaluria Drug

Figure 2. Primary Hyperoxaluria Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Primary Hyperoxaluria Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Primary Hyperoxaluria Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Primary Hyperoxaluria Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of ALLN-230

Figure 10. Product Picture of DCR-PHXC

Figure 11. Product Picture of ALN-GO1

Figure 12. Product Picture of Others

Figure 13. Global Primary Hyperoxaluria Drug Sales Market Share by Type in 2021

Figure 14. Global Primary Hyperoxaluria Drug Revenue Market Share by Type (2017-2022)

Figure 15. Primary Hyperoxaluria Drug Consumed in Hospital

Figure 16. Global Primary Hyperoxaluria Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 17. Primary Hyperoxaluria Drug Consumed in Clinic

Figure 18. Global Primary Hyperoxaluria Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 19. Primary Hyperoxaluria Drug Consumed in Others

Figure 20. Global Primary Hyperoxaluria Drug Market: Others (2017-2022) & (K Pcs)

Figure 21. Global Primary Hyperoxaluria Drug Sales Market Share by Application (2017-2022)

Figure 22. Global Primary Hyperoxaluria Drug Revenue Market Share by Application in 2021

Figure 23. Primary Hyperoxaluria Drug Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Primary Hyperoxaluria Drug Revenue Market Share by Company in 2021

Figure 25. Global Primary Hyperoxaluria Drug Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Primary Hyperoxaluria Drug Revenue Market Share by Geographic Region in 2021

Figure 27. Global Primary Hyperoxaluria Drug Sales Market Share by Region (2017-2022)

Figure 28. Global Primary Hyperoxaluria Drug Revenue Market Share by Country/Region in 2021

Figure 29. Americas Primary Hyperoxaluria Drug Sales 2017-2022 (K Pcs)

Figure 30. Americas Primary Hyperoxaluria Drug Revenue 2017-2022 ($ Millions)

Figure 31. APAC Primary Hyperoxaluria Drug Sales 2017-2022 (K Pcs)

Figure 32. APAC Primary Hyperoxaluria Drug Revenue 2017-2022 ($ Millions)

Figure 33. Europe Primary Hyperoxaluria Drug Sales 2017-2022 (K Pcs)

Figure 34. Europe Primary Hyperoxaluria Drug Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Primary Hyperoxaluria Drug Sales 2017-2022 (K Pcs)

Figure 36. Middle East & Africa Primary Hyperoxaluria Drug Revenue 2017-2022 ($ Millions)

Figure 37. Americas Primary Hyperoxaluria Drug Sales Market Share by Country in 2021

Figure 38. Americas Primary Hyperoxaluria Drug Revenue Market Share by Country in 2021

Figure 39. United States Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Primary Hyperoxaluria Drug Sales Market Share by Region in 2021

Figure 44. APAC Primary Hyperoxaluria Drug Revenue Market Share by Regions in 2021

Figure 45. China Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Primary Hyperoxaluria Drug Sales Market Share by Country in 2021

Figure 52. Europe Primary Hyperoxaluria Drug Revenue Market Share by Country in 2021

Figure 53. Germany Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Primary Hyperoxaluria Drug Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Primary Hyperoxaluria Drug Revenue Market Share by Country in 2021

Figure 60. Egypt Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Primary Hyperoxaluria Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Primary Hyperoxaluria Drug in 2021

Figure 66. Manufacturing Process Analysis of Primary Hyperoxaluria Drug

Figure 67. Industry Chain Structure of Primary Hyperoxaluria Drug

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles